ClinicalTrials.Veeva

Menu

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

W.L. Gore & Associates logo

W.L. Gore & Associates

Status

Invitation-only

Conditions

Pararenal Aortic Aneurysm
Abdominal Aortic Aneurysm
Thoracoabdominal Aortic Aneurysm

Treatments

Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)

Study type

Interventional

Funder types

Industry

Identifiers

NCT06578741
AAA 24-01

Details and patient eligibility

About

This study aims to confirm that the benefit-risk assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) remains positive in real-world use and to ensure the adequacy of the TAMBE Device training program.

Full description

A maximum of 300 adult subjects will be enrolled at up to 60 U.S. centers, with a minimum of 70 subjects enrolled at study centers with no prior experience using the TAMBE Device. Subjects will have follow-up at 1 month, 6 months, 12 months and annually thereafter through 10 years post implant.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The subject is / has:

  1. Treated with the aortic component of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Aortic Component) to allow endovascular repair of an aortic disease involving the visceral vessels.
  2. Age ≥18 years at the time of informed consent signature.
  3. An Informed Consent Form signed by subject or legal representative.

Exclusion criteria

The subject is / has:

  1. Any contraindications for the TAMBE Device according to the IFU.
  2. Planned parallel grafting with the TAMBE Aortic Component.
  3. Intent to modify TAMBE Aortic Component (e.g., in situ fenestration).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

Single Arm
Other group
Description:
Treatment with GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)
Treatment:
Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)

Trial contacts and locations

1

Loading...

Central trial contact

Nickole Garvey; Megan Mitchell

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems